Drugmaker Eli Lilly tops 2Q expectations, raises forecast
INDIANAPOLIS - Eli Lilly raised its 2019 forecast after a jump in sales from the diabetes treatment Trulicity helped push the drugmaker to a better-than-expected second quarter. Re…
INDIANAPOLIS - Eli Lilly raised its 2019 forecast after a jump in sales from the diabetes treatment Trulicity helped push the drugmaker to a better-than-expected second quarter. Re…